(Q40754178)

23 September 2017

Synthesis and biological activities of fluorinated chalcone derivatives (English)

1 reference

23 September 2017

Chika Nakamura

1

1 reference

23 September 2017

Nobuhide Kawasaki

2

1 reference

23 September 2017

Hideki Miyataka

3

1 reference

23 September 2017

Ezhuthachan Jayachandran

4

1 reference

23 September 2017

In Ho Kim

5

1 reference

23 September 2017

Kenneth L Kirk

6

1 reference

23 September 2017

Takeo Taguchi

7

1 reference

23 September 2017

Yoshio Takeuchi

8

1 reference

23 September 2017

Hitoshi Hori

9

1 reference

23 September 2017

Toshio Satoh

10

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Bioorganic & Medicinal Chemistry

23 September 2017

1 reference

23 September 2017

10

1 reference

23 September 2017

699-706

1 reference

23 September 2017

3

1 reference

Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900319-4

7 January 2021

Leukotrienes are potent constrictors of human bronchi

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900319-4

7 January 2021

Leukotrienes and slow reacting substance of anaphylaxis (SRS-A).

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900319-4

7 January 2021

Quantitative Structure-Activity Relationship of Catechol Derivatives Inhibiting 5-Lipoxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900319-4

7 January 2021

Inhibition of Prostaglandin and Leukotriene Biosynthesis by Gingerols and Diarylheptanoids

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900319-4

7 January 2021

Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900319-4

7 January 2021

3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900319-4

7 January 2021

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900319-4

7 January 2021

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900319-4

7 January 2021

Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900319-4

7 January 2021

Synthesis and anti lipid-peroxidation activity of hydroquinone monoalkyl ethers

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900319-4

7 January 2021

Mechanism of antihepatotoxic activity of glycyrrhizin. I: Effect on free radical generation and lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900319-4

7 January 2021

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900319-4

7 January 2021

FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900319-4

7 January 2021

10.1016/S0968-0896(01)00319-4

Identifiers

DOI

1 reference

23 September 2017

1 reference